ALXO Insider Trading Activity and SEC Form 4 Filings
ALXO insider trading summary
Over the past 12 months, insiders at Alx Oncology Holdings Inc (ALXO) reported 7 sales worth $43K by 2 insiders and 1 open-market purchase worth $5.0M by 1 insider on SEC Form 4. Net insider buying was $5.0M.
Latest ALXO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Jason Lettmann | Chief Executive Officer | Sell | $4K (2,230 @ $1.93) |
| Aug 17, 2026 | Shelly Wong | SVP, Finance and CAO | Sell | $1K (573 @ $1.93) |
| Jul 1, 2026 | Shelly Wong | SVP, Finance and CAO | Sell | $3K (1,404 @ $2.04) |
| Mar 19, 2026 | Shelly Pinto | SVP, Finance and CAO | Sell | $2K (903 @ $2.17) |
| Mar 19, 2026 | Jason Lettmann | Chief Executive Officer | Sell | $27K (12,311 @ $2.17) |
| Feb 18, 2026 | Shelly Pinto | SVP, Finance and CAO | Sell | $1K (565 @ $2.27) |
| Feb 2, 2026 | Corey S Goodman | Insider | Buy | $5.0M (3,184,713 @ $1.57) |
| Jan 6, 2026 | Shelly Pinto | SVP, Finance and CAO | Sell | $4K (3,925 @ $1.11) |
| Sep 17, 2025 | Jason Lettmann | Chief Executive Officer | Buy | $77K (71,163 @ $1.08) |
| Sep 16, 2025 | Jason Lettmann | Chief Executive Officer | Buy | $22K (21,070 @ $1.07) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.